Compounds > ecteinascidin 743
Page last updated: 2024-09-02

ecteinascidin 743 and Kahler Disease

ecteinascidin 743 has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amodio, N; Arbitrio, M; Barbieri, V; Botta, C; Caracciolo, D; Cucè, M; Di Martino, MT; Di Vito, A; Gallo Cantafio, ME; Grillone, K; Maltese, L; Riillo, C; Rossi, M; Scionti, F; Siciliano, MA; Staropoli, N; Tagliaferri, P; Tassone, P; Zuccalà, V1

Other Studies

1 other study(ies) available for ecteinascidin 743 and Kahler Disease

ArticleYear
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma.
    Journal of hematology & oncology, 2019, 03-21, Volume: 12, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Humans; Killer Cells, Natural; Multiple Myeloma; Trabectedin

2019